Skip to main content

RT @RichardPAConway: Fleischmann et al. Safety of TYK2i Deucravacitinib in PsA/PsO in terms of labs. Really no effect on

Nov 14, 2022 7:45 am
Social Author Name
Richard Conway
Tweet Content
Fleischmann et al. Safety of TYK2i Deucravacitinib in PsA/PsO in terms of labs. Really no effect on lab values other than increase in trigs. Guess this is why they don't have lab monitoring on label? @RheumNow #ACR22 Abstr#2132 https://t.co/ueIVKQc6jr https://t.co/u99QE71VQ5
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×